Compare NNNN & CBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | CBL |
|---|---|---|
| Founded | 2021 | 1978 |
| Country | Germany | United States |
| Employees | 27 | 500 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | 1995 |
| Metric | NNNN | CBL |
|---|---|---|
| Price | $25.50 | $47.72 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | 12.8K | ★ 162.7K |
| Earning Date | 04-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.00% |
| EPS Growth | N/A | ★ 132.09 |
| EPS | N/A | ★ 4.34 |
| Revenue | N/A | ★ $578,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $446.57 | ★ $10.10 |
| Revenue Growth | N/A | ★ 12.18 |
| 52 Week Low | $7.03 | $24.03 |
| 52 Week High | $55.65 | $45.86 |
| Indicator | NNNN | CBL |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 75.18 |
| Support Level | $26.31 | $36.41 |
| Resistance Level | $30.21 | N/A |
| Average True Range (ATR) | 2.10 | 1.23 |
| MACD | -0.28 | -0.04 |
| Stochastic Oscillator | 20.78 | 95.99 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
CBL & Associates Properties Inc is a real estate investment trust. The company engages in the ownership, development, acquisition, leasing, management and operation of regional shopping malls, outlet centers, lifestyle centers, open-air centers and other properties. CBL's sales predominantly derive from leasing arrangements with retail tenants. The company also generates revenue from management and development fees, as well as sales of its real estate assets. CBL expands its portfolio of assets through activities such as redevelopment, renovation, and expansion.